apomorphine has been researched along with Sleep Wake Disorders in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abril, B; Aerts, C; Anheim, M; Arnulf, I; Benard-Serre, N; Castelnovo, G; Corbillé, AG; De Cock, VC; Devos, D; Dodet, P; Doulazmi, M; Drapier, S; Eusebio, A; Fantini, ML; Lacombe, S; Lambert, I; Lebouteux, M; Leclair-Visonneau, L; Leu-Semenescu, S; Marques, A; Monaca, C; Olivet, H; Roze, E; Ruppert, E; Sallansonnet-Froment, M; Vidailhet, M; Vitello, N | 1 |
| Ares, B; Castro, A; Fernández-Pajarín, G; Sesar, Á | 1 |
| Chaudhuri, KR; Evans, A; Qamar, MA; Rosa-Grilo, M | 1 |
| Schnitzler, A; Südmeyer, M; Wojtecki, L | 1 |
| Carballo-Cordero, M; Giménez de Béjar, V | 1 |
| Cornette, F; Haba-Rubio, J; Krieger, J; Lainey, E; Luthringer, R; Macher, JP; Staner, L | 1 |
| Burov, IuV; Viglinskaia, IV | 1 |
| Marsden, CD; Nordera, G; Stocchi, F | 1 |
| Ellis, CM; Ray Chaudhuri, K; Reuter, I | 1 |
3 review(s) available for apomorphine and Sleep Wake Disorders
| Article | Year |
|---|---|
The efficacy of apomorphine - A non-motor perspective.
Topics: Animals; Antiparkinson Agents; Apomorphine; Autonomic Nervous System Diseases; Disruptive, Impulse Control, and Conduct Disorders; Humans; Mental Disorders; Parkinson Disease; Sleep Wake Disorders | 2016 |
[Current treatment strategies for Parkinson's disease].
Topics: Aged; Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Apomorphine; Critical Care; Deep Brain Stimulation; Dementia; Depression; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Europe; Female; Humans; Infusion Pumps, Implantable; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Psychotic Disorders; Sleep Wake Disorders; Tremor | 2011 |
Strategies for treating patients with advanced Parkinson's disease with disastrous fluctuations and dyskinesias.
Topics: Antiparkinson Agents; Apomorphine; Catechol O-Methyltransferase Inhibitors; Dopamine Agonists; Enzyme Inhibitors; Globus Pallidus; Humans; Levodopa; Mental Disorders; Movement Disorders; Parkinson Disease; Sleep Wake Disorders; Stereotaxic Techniques; Thalamus | 1997 |
3 trial(s) available for apomorphine and Sleep Wake Disorders
| Article | Year |
|---|---|
Safety and efficacy of subcutaneous night-time only apomorphine infusion to treat insomnia in patients with Parkinson's disease (APOMORPHEE): a multicentre, randomised, controlled, double-blind crossover study.
Topics: Adult; Aged; Aged, 80 and over; Apomorphine; Cross-Over Studies; Double-Blind Method; Humans; Middle Aged; Parkinson Disease; Quality of Life; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders; Treatment Outcome | 2022 |
Acute low single dose of apomorphine reduces periodic limb movements but has no significant effect on sleep arousals: a preliminary report.
Topics: Apomorphine; Arousal; Dopamine; Dopamine Agonists; Electrooculography; Female; Humans; Male; Middle Aged; Nocturnal Myoclonus Syndrome; Polysomnography; Sleep; Sleep Wake Disorders; Synaptic Transmission | 2003 |
Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome.
Topics: Adult; Aged; Antiparkinson Agents; Apomorphine; Drug Administration Schedule; Follow-Up Studies; Humans; Injections, Subcutaneous; Levodopa; Middle Aged; Parkinson Disease; Restless Legs Syndrome; Sleep Wake Disorders | 1999 |
4 other study(ies) available for apomorphine and Sleep Wake Disorders
| Article | Year |
|---|---|
Evaluating the Efficacy of Nocturnal Continuous Subcutaneous Apomorphine Infusion in Sleep Disorders in Advanced Parkinson's Disease: The APO-NIGHT Study.
Topics: Aged; Aged, 80 and over; Apomorphine; Dopamine Agonists; Female; Follow-Up Studies; Humans; Infusions, Subcutaneous; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Sleep Wake Disorders | 2016 |
[Treatment of apomorphine infusion adverse effects: subcutaneous nodules and neuropsychiatric complications].
Topics: Adrenal Cortex Hormones; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Cholinesterase Inhibitors; Combined Modality Therapy; Disease Susceptibility; Dopamine Agonists; Drug Eruptions; Hallucinations; Humans; Infusions, Subcutaneous; Mental Disorders; Parkinson Disease; Physical Therapy Modalities; Psychomotor Agitation; Psychoses, Substance-Induced; Severity of Illness Index; Sleep Wake Disorders | 2012 |
[Effect of psychotropic drugs on sleep disorders in rats during alcohol withdrawal].
Topics: Alcoholism; Animals; Anti-Anxiety Agents; Apomorphine; Benzodiazepines; Benzodiazepinones; Haloperidol; Humans; Male; Psychotropic Drugs; Rats; Sleep Wake Disorders; Sodium Oxybate; Substance Withdrawal Syndrome | 1981 |
[Sulpiride in pediatrics].
Topics: Adolescent; Apomorphine; Benzamides; Chemical Phenomena; Chemistry; Child; Child Behavior Disorders; Child, Preschool; Humans; Infant; Infant, Newborn; Nervous System Diseases; Neurotic Disorders; Peptic Ulcer; Psychotic Disorders; Pyrrolidines; Sleep Wake Disorders; Tranquilizing Agents | 1973 |